Recombinant Salaria pavo Rhodopsin (rho)

Introduction to Recombinant Salaria pavo Rhodopsin (rho)

Recombinant Salaria pavo Rhodopsin (rho) is a genetically engineered form of the visual pigment protein derived from the Peacock blenny (Salaria pavo), a marine fish species. Rhodopsin, a G-protein-coupled receptor (GPCR), is critical for phototransduction in rod photoreceptor cells, enabling dim-light vision . The recombinant variant allows researchers to study its structural and functional properties without isolating the protein directly from native tissues.

Sequence and Domains

The full-length recombinant protein consists of 354 amino acids (UniProt ID: Q9YGZ3) . Key structural features include:

• Seven transmembrane (7TM) helices: Characteristic of GPCRs, facilitating light signal transduction.

• N-terminal cap: Stabilizes the protein during biosynthesis and contributes to dark-state stability .

• Retinal-binding lysine residue (K296): Forms a protonated Schiff base with 11-cis-retinal, essential for light absorption .

Table 1: Sequence Features of Recombinant Salaria pavo Rhodopsin

Biophysical Properties

• Absorption spectrum: Peak sensitivity in the blue-green range (~500 nm), typical of aquatic rhodopsins .

• Thermal stability: Dependent on proper folding and retinal binding; mutations destabilize the protein .

Expression and Production

Recombinant Salaria pavo Rhodopsin is produced in heterologous expression systems (e.g., HEK293T or photoreceptor cell lines) to ensure high yields and purity .

Mechanistic Studies of Retinal Diseases

• Disease modeling: Mutations in rhodopsin cause retinitis pigmentosa (RP) and congenital stationary night blindness (CSNB) . Recombinant Salaria pavo Rhodopsin enables comparative studies of pathogenic mutations (e.g., P23H, R135L) .

• Pharmacological rescue: Testing retinal analogs or chaperones (e.g., 9-cis-retinal) to restore folding in misfolded mutants .

Key Research Findings

• Energy metabolism dysfunction: Overexpression of wild-type or mutant rhodopsin disrupts oxidative phosphorylation and glycolysis in photoreceptor cells, accelerating degeneration .

• Localization patterns: Sector RP-associated mutants (e.g., L31Q) traffic primarily to rod outer segments in transgenic models, with degeneration mitigated by dark rearing or blocking chromophore binding .

Future Directions

• Gene therapy: RNA replacement strategies (e.g., siRNA-resistant RHO mRNA) to suppress mutant rhodopsin expression while restoring wild-type function .

• High-throughput screening: Identifying small-molecule correctors for pathogenic variants using deep mutational scanning (DMS) .